Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.

Giovanni MazzolaLucia AdamoliVincenza CalvarusoFabio Salvatore MacalusoPietro CollettiSergio MazzolaAdriana CervoMarcello TrizzinoFrancesco Di LorenzoChiara IariaTullio PrestileoAmbrogio OrlandoVito Di MarcoAntonio Cascio

Published in: Infection (2018)

Differently from other studies, we detected the unreliability of APRI and FIB-4 for the assessment of liver fibrosis in both HCV mono-infected and HIV/HCV co-infected patients.

Keyphrases

hepatitis c virus
liver fibrosis
human immunodeficiency virus
antiretroviral therapy
hiv infected
hiv positive
hiv aids
south africa